Cargando…

2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma

BACKGROUND: The cavitating mesenteric lymph node syndrome (CMLNS) is a rare manifestation of celiac disease, with an estimated mortality rate of 50%. Specific infections and malignant lymphoma may complicate its clinical course and contribute to its poor prognosis. Diagnosing the underlying cause of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pojoga, Cristina, Ciobanu, Lidia, Badea, Alexandru Florin, Boţan, Emil, Caraiani, Cosmin, Hagiu, Claudia, Băciuţ, Grigore, Badea, Radu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579742/
https://www.ncbi.nlm.nih.gov/pubmed/23399324
http://dx.doi.org/10.1186/1471-230X-13-26
_version_ 1782260155887386624
author Pojoga, Cristina
Ciobanu, Lidia
Badea, Alexandru Florin
Boţan, Emil
Caraiani, Cosmin
Hagiu, Claudia
Băciuţ, Grigore
Badea, Radu
author_facet Pojoga, Cristina
Ciobanu, Lidia
Badea, Alexandru Florin
Boţan, Emil
Caraiani, Cosmin
Hagiu, Claudia
Băciuţ, Grigore
Badea, Radu
author_sort Pojoga, Cristina
collection PubMed
description BACKGROUND: The cavitating mesenteric lymph node syndrome (CMLNS) is a rare manifestation of celiac disease, with an estimated mortality rate of 50%. Specific infections and malignant lymphoma may complicate its clinical course and contribute to its poor prognosis. Diagnosing the underlying cause of CMLNS can be challenging. This is the first report on contrast enhanced ultrasound (CEUS) findings in enteropathy associated T-cell lymphoma (EATL) complicating CMLNS in a gluten-free compliant patient with persistent symptoms and poor outcome. CASE PRESENTATION: We present the case of a 51-year old Caucasian male patient, diagnosed with celiac disease and CMLNS. Despite his compliance to the gluten-free diet the symptoms persisted and we eventually considered the possible development of malignancy. No mucosal changes suggestive of lymphoma were identified with capsule endoscopy. Low attenuation mesenteric lymphadenopathy, without enlarged small bowel segments were seen on computed tomography. CEUS revealed arterial rim enhancement around the necrotic mesenteric lymph nodes, without venous wash-out. No malignant cells were identified on laparoscopic mesenteric lymph nodes biopsies. The patient died due to fulminant liver failure 14 months later; the histopathological examination revealed CD3/CD30-positive atypical T-cell lymphocytes in the liver, mesenteric tissue, spleen, gastric wall, kidney, lung and bone marrow samples; no malignant cells were present in the small bowel samples. CONCLUSIONS: CEUS findings in EATL complicating CMLNS include arterial rim enhancement of the mesenteric tissue around the cavitating lymph nodes, without venous wash-out. This vascular pattern is not suggestive for neoangiogenesis, as arteriovenous shunts from malignant tissues are responsible for rapid venous wash-out of the contrast agent. CEUS failed to provide a diagnosis in this case.
format Online
Article
Text
id pubmed-3579742
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35797422013-02-23 2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma Pojoga, Cristina Ciobanu, Lidia Badea, Alexandru Florin Boţan, Emil Caraiani, Cosmin Hagiu, Claudia Băciuţ, Grigore Badea, Radu BMC Gastroenterol Case Report BACKGROUND: The cavitating mesenteric lymph node syndrome (CMLNS) is a rare manifestation of celiac disease, with an estimated mortality rate of 50%. Specific infections and malignant lymphoma may complicate its clinical course and contribute to its poor prognosis. Diagnosing the underlying cause of CMLNS can be challenging. This is the first report on contrast enhanced ultrasound (CEUS) findings in enteropathy associated T-cell lymphoma (EATL) complicating CMLNS in a gluten-free compliant patient with persistent symptoms and poor outcome. CASE PRESENTATION: We present the case of a 51-year old Caucasian male patient, diagnosed with celiac disease and CMLNS. Despite his compliance to the gluten-free diet the symptoms persisted and we eventually considered the possible development of malignancy. No mucosal changes suggestive of lymphoma were identified with capsule endoscopy. Low attenuation mesenteric lymphadenopathy, without enlarged small bowel segments were seen on computed tomography. CEUS revealed arterial rim enhancement around the necrotic mesenteric lymph nodes, without venous wash-out. No malignant cells were identified on laparoscopic mesenteric lymph nodes biopsies. The patient died due to fulminant liver failure 14 months later; the histopathological examination revealed CD3/CD30-positive atypical T-cell lymphocytes in the liver, mesenteric tissue, spleen, gastric wall, kidney, lung and bone marrow samples; no malignant cells were present in the small bowel samples. CONCLUSIONS: CEUS findings in EATL complicating CMLNS include arterial rim enhancement of the mesenteric tissue around the cavitating lymph nodes, without venous wash-out. This vascular pattern is not suggestive for neoangiogenesis, as arteriovenous shunts from malignant tissues are responsible for rapid venous wash-out of the contrast agent. CEUS failed to provide a diagnosis in this case. BioMed Central 2013-02-11 /pmc/articles/PMC3579742/ /pubmed/23399324 http://dx.doi.org/10.1186/1471-230X-13-26 Text en Copyright ©2013 Pojoga et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Pojoga, Cristina
Ciobanu, Lidia
Badea, Alexandru Florin
Boţan, Emil
Caraiani, Cosmin
Hagiu, Claudia
Băciuţ, Grigore
Badea, Radu
2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma
title 2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma
title_full 2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma
title_fullStr 2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma
title_full_unstemmed 2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma
title_short 2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma
title_sort 2d ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy t cell lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579742/
https://www.ncbi.nlm.nih.gov/pubmed/23399324
http://dx.doi.org/10.1186/1471-230X-13-26
work_keys_str_mv AT pojogacristina 2dultrasonographyandcontrastenhancedultrasoundfortheevaluationofcavitatingmesentericlymphnodesyndromeinapatientwithrefractoryceliacdiseaseandenteropathytcelllymphoma
AT ciobanulidia 2dultrasonographyandcontrastenhancedultrasoundfortheevaluationofcavitatingmesentericlymphnodesyndromeinapatientwithrefractoryceliacdiseaseandenteropathytcelllymphoma
AT badeaalexandruflorin 2dultrasonographyandcontrastenhancedultrasoundfortheevaluationofcavitatingmesentericlymphnodesyndromeinapatientwithrefractoryceliacdiseaseandenteropathytcelllymphoma
AT botanemil 2dultrasonographyandcontrastenhancedultrasoundfortheevaluationofcavitatingmesentericlymphnodesyndromeinapatientwithrefractoryceliacdiseaseandenteropathytcelllymphoma
AT caraianicosmin 2dultrasonographyandcontrastenhancedultrasoundfortheevaluationofcavitatingmesentericlymphnodesyndromeinapatientwithrefractoryceliacdiseaseandenteropathytcelllymphoma
AT hagiuclaudia 2dultrasonographyandcontrastenhancedultrasoundfortheevaluationofcavitatingmesentericlymphnodesyndromeinapatientwithrefractoryceliacdiseaseandenteropathytcelllymphoma
AT baciutgrigore 2dultrasonographyandcontrastenhancedultrasoundfortheevaluationofcavitatingmesentericlymphnodesyndromeinapatientwithrefractoryceliacdiseaseandenteropathytcelllymphoma
AT badearadu 2dultrasonographyandcontrastenhancedultrasoundfortheevaluationofcavitatingmesentericlymphnodesyndromeinapatientwithrefractoryceliacdiseaseandenteropathytcelllymphoma